CureVac - Ingmar Hoerr, CEO

1,222 번 감상됨
8.1
투표해 주셔서 감사합니다. 귀하의 투표가 저장되었으며 잠시 후 표시됩니다.
아니오
프로필 북마크에 추가됨.
동영상 설명

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

추가됨: 29 3월 2017
코멘트